Author Details

Проценко, Светлана Анатольевна

Issue Section Title File
Vol 16, No 3 (2014) Articles Modern options in personalized therapy of metastatic cutaneous melanoma
Vol 17, No 3 (2015) Articles Osobennosti profilya toksichnosti ingibitorov BRAF i MEK
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Assessment and correction of the geriatric status of patients with metastatic colorectal cancer during the first-line systemic therapy PDF
(Rus)
Vol 23, No 3 (2021) CLINICAL ONCOLOGY Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer PDF
(Rus)
Vol 24, No 2 (2022) CLINICAL ONCOLOGY Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study PDF
(Rus)
Vol 26, No 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies